SCHEMBL23830266

SCHEMBL23830266

CCc1nccn1Cc1ccc(N2CC3(CC3)C2)nc1F

nearest known ligand 0.39

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 12/20 0.39
ALDH1A1 P00352 1/20 0.36
KLKB1 P03952 3/20 0.34
CRHR1 P34998 1/20 0.32
EGFR P00533 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21712914 0.87 KLKB1 (0.40) KCNH2ALDH1A1KLKB1
SCHEMBL23830265 0.87 KCNH2 (0.39) KCNH2ALDH1A1KLKB1CRHR1
SCHEMBL23830157 0.86 KCNH2 (0.43) KCNH2ALDH1A1CRHR1EGFR
SCHEMBL23830217 0.86 KCNH2 (0.38) KCNH2ALDH1A1KLKB1CRHR1EGFR
SCHEMBL23830231 0.84 ALDH1A1 (0.37) KCNH2ALDH1A1
SCHEMBL23781336 0.84 ALDH1A1 (0.43) KCNH2ALDH1A1KLKB1
SCHEMBL23830205 0.83 KCNH2 (0.38) KCNH2ALDH1A1KLKB1
SCHEMBL23830174 0.76 KLKB1 (0.33) KLKB1
SCHEMBL23830250 0.74 KLKB1 (0.41) KLKB1
SCHEMBL23769136 0.71 KLKB1 (0.38) ALDH1A1KLKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240076286-A1 HETEROAROMATIC CARBOXAMIDE DERIVATIVES AS PLASMA KALLIKREIN INHIBITORS BOEHRINGER INGELHEIM INT (DE) 2024-03-07 US disclosed
US-20240002363-A1 HETEROAROMATIC CARBOXAMIDE DERIVATIVES AS PLASMA KALLIKREIN INHIBITORS BOEHRINGER INGELHEIM INT (DE) 2024-01-04 US disclosed
US-11760745-B2 Heteroaromatic carboxamide derivatives as plasma kallikrein inhibitors BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2023-09-19 US disclosed
US-20210292301-A1 HETEROAROMATIC CARBOXAMIDE DERIVATIVES AS PLASMA KALLIKREIN INHIBITORS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2021-09-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210292301-A1 HETEROAROMATIC CARBOXAMIDE DERIVATIVES AS PLASMA KALLIKREIN INHIBITORS KLKB1, KLK5, KLK1 KCNH2 782/4885ALDH1A1 1223/4885KLKB1 1/4885
US-11760745-B2 Heteroaromatic carboxamide derivatives as plasma kallikrein inhibitors KLKB1, KLK5, KLK1 KCNH2 782/4885ALDH1A1 1223/4885KLKB1 1/4885
US-20240002363-A1 HETEROAROMATIC CARBOXAMIDE DERIVATIVES AS PLASMA KALLIKREIN INHIBITORS KLKB1, KLK5, KLK1 KCNH2 782/4885ALDH1A1 1223/4885KLKB1 1/4885
US-20240076286-A1 HETEROAROMATIC CARBOXAMIDE DERIVATIVES AS PLASMA KALLIKREIN INHIBITORS KLKB1, KLK5, KLK1 KCNH2 782/4885ALDH1A1 1223/4885KLKB1 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.